November 21, 2016
The Fall 2016 issue of the Partners Biobank newsletter for Biobank participants has been released.
September 6, 2016
Drs. I-Cheng Ho and Hui-Hsin Chang of Brigham and Women’s Hospital recently published a paper in Arthritis & Rheumatology on the results of a study they completed using samples from the Partners Biobank. This study investigated the relationship between a variation in a gene and the risk for the development of rheumatoid arthritis (RA). Drs. Ho and Chang found that the variation in this gene leads to increased activity of immune cells, which can cause the inflammation characteristic of RA.
March 22, 2016
Dr. Kathiresan (pictured) and his team of investigators, led by Pradeep Natarajan, MD, and research coordinator Erina Kii in the Center for Human Genetic Research at Massachusetts General Hospital, are looking for a needle in a haystack.
Sekar Kathiresan, MD, uses the Partners Biobank to conduct research that would otherwise be impossible using traditional research methods.
September 3, 2015
We are happy to bring you the newest issue of our Partners Biobank newsletter created for participants in the Biobank project. The Biobank is a collection of samples and data from patients at Brigham and Women’s Hospital and Massachusetts General Hospital that are used for research. It’s been a busy and exciting year for the project.
August 14, 2015
The next large project for the Biobank is to genotype 10,000 DNA samples by the end of 2015 and a total of 25,000-50,000 samples over the next 2-3 years. Genotyping is the process of detecting which variants of genes a person has. These data, generated by analyzing the stored DNA of participants in the Biobank, will provide researchers with valuable information to further understand the influence of genes on health. The project will lead to a greater understanding of the pathways of human disease, and allow us to develop better diagnostics and targeted therapeutics for future generations.
March 16, 2015
Dr. Jordan Smoller of Massachusetts General Hospital identified a unique group of 1000 DNA samples from the Partners Healthcare Biobank that will be used as control samples. As a member of the Psychiatric Genomics Consortium, Smoller and his colleagues will use the samples for studies that are investigating the genetics of complicated psychiatric disorders such as autism and depression. Understanding the genetic basis of these diseases will hopefully lay the building blocks for better treatment and care in the future.